article thumbnail

Top 12 BioPharma / Pharmaceutical Recruiters, Headhunters, and Executive Search Firms

Jake Jorgovan

If you’re in the BioPharma and Pharmaceutical industries, your most valuable resource isn’t just the latest breakthrough drug or cutting-edge technology. Enter the world of executive search firms, headhunters, and recruiters specializing in the BioPharma and Pharmaceutical industries. Let’s dive in.

Biopharma 130
article thumbnail

Top Life Science Recruiters, Headhunters, & Executive Search Firms

Jake Jorgovan

The firm focuses on recruiting top-tier leadership for the pharmaceutical, biotechnology, medical technology, and healthcare sectors. They cater to various subsectors including pharmaceuticals, medical devices, life sciences technology, and biotechnology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 11 Life Science Consultants & Consulting Firms

Jake Jorgovan

They offer a wealth of expertise in biotechnology, pharmaceuticals, and healthcare, guiding companies through product development, market strategies, and regulatory compliance. The company addresses the challenges faced by pharmaceutical, medical device, biotechnology, and diagnostic firms. What Life Science Consultant Will You Choose?

article thumbnail

Growth Perspectives: Key Highlights from DCAT 2024

Frost & Sullivan

Fuelling Growth: Strategic Investments, Acquisitions, and Expansions Samsung Biologics unveiled plans to expand capacity and geographic reach by initiating the construction of Bio Campus II with a $6 billion investment scheduled to begin operations in 2025 while completing its CGMP antibody-drug conjugate manufacturing facility within 2024.

article thumbnail

LHS Expert Insights: ESG Issues for Life Science Innovators

LaVoie Health Science Blog

Paul Sagan, Vice President of Investor Relations and Corporate Communications, discusses the growing investment case for ESG reporting within the biotechnology field, the unique challenges of developing an ESG approach in the life sciences, and the important considerations posed by potential new SEC recommendations and international ESG standards.